Keymedsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2017-01-03
Share capital
50,000.00 PLN
Registered address
ul. Michała Kleofasa Ogińskiego 1A/Ii piętro, 58-506 Jelenia Góra, Poland
Electronic delivery address
AE:PL-41000-63379-IRTFB-09

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 4 of 6 financial statements were filed late (the longest delay 822 days for 2022).

  • 2025not filed
  • 202414/10/2025
  • 202314/10/2025
  • 202214/10/2025
  • 202115/12/2022
  • 202002/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue
This companyUSD 1.14mMedianUSD 1.06mAverageUSD 22.40m
Net profit
This companyUSD 61.63kMedianUSD 37.33kAverageUSD 880.24k
Operating costs
This companyUSD 911.48kMedianUSD 922.77kAverageUSD 21.08m
Assets
This companyUSD 308.13kMedianUSD 608.93kAverageUSD 11.85m

Public procurement

6 tenders recorded as contractor: 4 national ($67,290) and 2 EU ($47,891).

SubjectAmount
Supply of foodstuffs for special medical purposes, ENT medical devices, utensils and equipment for obtaining autologous dressings
$8,752
Supply of medical devices
$39,139
Supply of medical devices in 35 lots
$8,386

Trademarks

Keymed holds 1 active trademark registered with the Polish Patent Office. 2 applications are pending. The first mark was filed in 2024.

MarkNumberClassesStatusProtected until
DO RANY PRZYŁÓŻ KeyMed MEDYCYNA REGENERACYJNAZ.5656925, 10, 35, 39, 41, 42, 44Protected Feb 5, 2034
LONGEVITY SHOT THERAPYZ.5879615, 10, 35, 41, 44Application pending –
E-PRFZ.5878515, 10, 35, 41, 42, 44Application pending –
MarkProtected until
DO RANY PRZYŁÓŻ KeyMed MEDYCYNA REGENERACYJNAFeb 5, 2034
LONGEVITY SHOT THERAPY–
E-PRF–

Authorized Representatives

Robert Cezary Kasperek – President of the Management Board & Attorney-in-fact (sole)

Manner of representation

§ 18(3) of the Articles of Association. For making and signing declarations on behalf of the company and incurring obligations on behalf of the company, in the case of obligations with a value not exceeding PLN 100,000 (100,000.00), each member of the management board is authorised to represent the company independently, whereas for making and signing declarations on behalf of the company and incurring obligations on behalf of the company with a value exceeding PLN 100,000 (PLN 100,000.00), joint action of two members of the management board or of one member of the management board jointly with a commercial proxy is required. In the case of a one-person management board, the company is represented by one person.

Ownership

OwnerSharesShare valueStake
Sylwia Kasperekage 55
910$12,830.9095%
Others
48$675.315%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2017-02-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

13 public aid cases recorded, with a total value of $555,538.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$1,904
Aid in the form of wage subsidies for the recruitment of workers with disabilities
$437
Aid in the form of wage subsidies for the recruitment of workers with disabilities
$505

European Funds

ProjectEU co-financing
Conducting research and development work in cooperation with a scientific institution to develop specialist wound dressings to support wound healing for medical applications
$953.6K

Competitors

Name
AsclepiosS.A.
BaylegS.A.
NettleS.A.
Centrum Zaopatrzenia Medycznego Cezal - WrocławS.A.
Curaleaf PolandS.A.
Zakmed sp. z o.o.sp. k.
Beautyeurope.Eu sp. z o.o.sp. k.
Gierthsp. z o.o.
Zdrowie Ze Znakiem Kangurasp. z o.o.
Arjamedicalsp. z o.o.

Change history

DateEvent
2019-06-27Address change
2017-01-03Entered in the register

FAQ

Last updated: 2026-04-21